| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 18.32B | 18.94B | 18.17B | 19.26B | 16.79B |
| Gross Profit | 6.54B | 6.71B | 5.67B | 6.06B | 5.33B |
| EBITDA | 6.74B | 6.70B | 8.38B | 8.01B | 7.16B |
| Net Income | 5.14B | 5.23B | 4.92B | 4.53B | 3.98B |
Balance Sheet | |||||
| Total Assets | 66.75B | 62.75B | 60.25B | 57.48B | 60.58B |
| Cash, Cash Equivalents and Short-Term Investments | 14.50B | 12.68B | 11.22B | 10.18B | 10.01B |
| Total Debt | 4.57B | 3.72B | 3.43B | 3.92B | 2.28B |
| Total Liabilities | 16.15B | 15.96B | 15.71B | 16.20B | 21.79B |
| Stockholders Equity | 45.73B | 42.49B | 40.28B | 37.40B | 34.92B |
Cash Flow | |||||
| Free Cash Flow | 3.46B | 3.07B | 3.44B | 3.28B | 70.57M |
| Operating Cash Flow | 5.86B | 5.15B | 6.15B | 6.23B | 2.75B |
| Investing Cash Flow | -3.45B | -38.54M | -1.98B | -795.42M | 1.97B |
| Financing Cash Flow | -1.88B | -3.03B | -3.05B | -4.69B | -2.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$65.45B | 5.50 | 5.92% | 5.72% | 12.77% | -18.46% | |
74 Outperform | HK$21.30B | 8.82 | 5.04% | 4.97% | 10.96% | -4.09% | |
72 Outperform | HK$64.41B | 7.92 | 11.78% | 5.34% | -0.70% | 0.64% | |
72 Outperform | HK$21.37B | 8.50 | 8.00% | 3.47% | 2.30% | 2.47% | |
69 Neutral | HK$4.30B | 6.18 | 4.48% | 6.69% | -14.81% | -3.39% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$39.75B | 651.97 | 3.25% | 3.23% | 2.68% | 15.41% |